Physician profile
Tanner C Pearson
NPI 1528779436
$1,036.42
in general payments reported to CMS, 2019-2025
14 companies · $654 in 2025
The $654 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $383 · 2025: $654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $309.99 | 2024-2025 | Konect Resilia, Mitris Resilia Mitral Valve |
| Atricure, INC. | $206.71 | 2024-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Abiomed | $121.66 | 2025 | |
| Shockwave Medical, INC | $108.14 | 2025 | |
| Ethicon US, LLC | $94.59 | 2024-2025 | Prolene, Vistaseal, Echelon Flex |
| Solventum Corporation | $38.32 | 2024 | Activ.A.C. |
| Kerecis Limited | $27.74 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Merck Sharp & Dohme LLC | $23.35 | 2025 | Verquvo |
| Bridgebio Pharma, INC. | $22.40 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $20.17 | 2024 | Arcalyst |
| Medtronic, INC. | $18.22 | 2025 | Avalus |
| Arjo INC. | $16.51 | 2025 | |
| W. L. Gore & Associates, INC. | $14.71 | 2024 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Sanara Medtech INC. | $13.91 | 2024 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanner Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.